Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalization and ICU admission, the Netherlands, 9 October - 5 December 2023

C. Henri van Werkhoven, Anne-Wil Valk, Bente Smagge, Hester E. de Melker, Mirjam J. Knol, Susan J.M. Hahné, Susan van den Hof, Brechje de Gier
doi: https://doi.org/10.1101/2023.12.12.23299855

Article Information

doi 
https://doi.org/10.1101/2023.12.12.23299855
History 
  • December 13, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. C. Henri van Werkhoven1,2,
  2. Anne-Wil Valk1,
  3. Bente Smagge1,
  4. Hester E. de Melker1,
  5. Mirjam J. Knol1,
  6. Susan J.M. Hahné1,
  7. Susan van den Hof1 and
  8. Brechje de Gier1,*
  1. 1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
  2. 2Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
  1. ↵*Corresponding author; email: brechje.de.gier{at}rivm.nl
Back to top
Posted December 13, 2023.
Download PDF
Data/Code
Email
Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalization and ICU admission, the Netherlands, 9 October - 5 December 2023
C. Henri van Werkhoven, Anne-Wil Valk, Bente Smagge, Hester E. de Melker, Mirjam J. Knol, Susan J.M. Hahné, Susan van den Hof, Brechje de Gier
medRxiv 2023.12.12.23299855; doi: https://doi.org/10.1101/2023.12.12.23299855
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area